Table 2 Correlation of miR-1, 133a, 133b and 206 with overall survival
From: MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas
All RMS patients | Fusion-negative patients | |||||
|---|---|---|---|---|---|---|
miRNA | No. of patients | HR (95% CI) | Log-rank test ( P) | No. of patients | HR (95% CI) | Log-rank test ( P) |
miR-206 expression | ||||||
High miR-206 | 40 | 1 | 0.003 | 31 | 1 | 0.005 |
Med miR-206 | 79 | 2.1 (0.9–4.7) | 38 | 2.0 (0.6–6.5) | ||
Low miR-206 | 40 | 3.7 (1.7–8.4)** | 26 | 4.9 (1.6–15.0)** | ||
miR-1 expression | ||||||
High miR-1 | 40 | 1 | 0.515 | 16 | 1 | 0.229 |
Med miR-1 | 79 | 0.9 (0.5–1.6) | 45 | 0.9 (0.5–1.6) | ||
Low miR-1 | 40 | 1.2 (0.6–2.5) | 34 | 1.2 (0.6–2.5) | ||
miR-133a expression | ||||||
High miR-133a | 40 | 1 | 0.859 | 21 | 1 | 0.314 |
Med miR-133a | 79 | 1.2 (0.6–2.2) | 40 | 0.9 (0.3–2.9) | ||
Low miR-133a | 40 | 1.2 (0.6–2.4) | 34 | 1.7 (0.6–4.9) | ||
miR-133b expression | ||||||
High miR-133b | 40 | 1 | 0.355 | 21 | 1 | 0.161 |
Med miR-133b | 79 | 1.2 (0.6–2.3) | 44 | 1.4 (0.4–4.3) | ||
Low miR-133b | 40 | 1.6 (0.8–3.3) | 30 | 2.5 (0.8–7.8) | ||
